Serum BDNF Levels and Diabetic Retinopathy
Author Information
Author(s): Muacevic Alexander, Adler John R, K. U. Vivek Ram, Siddiqi Sheelu S, Debbarman Tanusree, Mukherjee Amit, Akhtar Naheed, Waris Abdul, Thacker Dimple, Shaista
Primary Institution: Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University (AMU), Aligarh, IND
Hypothesis
This study aims to determine the association of serum brain-derived neurotrophic factor (BDNF) levels with diabetic retinopathy (DR) in type 2 diabetic patients.
Conclusion
Patients with diabetic retinopathy were found to have lower serum BDNF levels compared to those without retinopathy, suggesting BDNF may serve as an early predictor for DR.
Supporting Evidence
- The mean serum BDNF in the control group was significantly higher than in the case group.
- Logistic regression analysis indicated that BDNF is a good predictor for diabetic retinopathy.
- The optimal cut-off value of serum BDNF for diagnosing DR was found to be 2139 pg/ml.
Takeaway
This study found that people with diabetic retinopathy have less of a special protein called BDNF in their blood, which might help doctors spot the problem early.
Methodology
A hospital-based case-control study with 44 diabetic patients with retinopathy and 44 without, measuring serum BDNF levels using ELISA.
Potential Biases
As a hospital-based case-control study, it may have inherent biases in participant selection.
Limitations
The study had a relatively small sample size and was conducted in a specific region, limiting generalizability.
Participant Demographics
Participants included 88 subjects with type 2 diabetes, 44 with retinopathy and 44 without, with a mix of genders.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI 0.933-1
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website